KPIs & Operating Metrics(New)
Balance Sheet
Cash Flow Statement
Daily Values
Growth Metrics
Income Statement
Amortization - IntangiblesConsolidated Net IncomeDepreciation & Amortization - TotalEBITEBITDAEBTEPS (Basic)EPS (Weighted Average and Diluted)Gross ProfitIncome from Continuing OperationsIncome towards Parent CompanyInterest & Investment IncomeInterest ExpensesNet Income towards Common StockholdersNon Operating IncomeOperating ExpensesOperating IncomeOther Non Operating IncomeOther Operating ExpensesProfit After TaxResearch & DevelopmentRestructuring CostsRevenueSelling, General & AdministrativeShares OutstandingShares Outstanding (Diluted Average)Shares Outstanding (Weighted Average)Tax ProvisionsTax Rate
Others
Ratios

Teladoc Health (TDOC) Interest Expenses (2022 - 2025)

Teladoc Health's Interest Expenses history spans 4 years, with the latest figure at $5.0 million for Q4 2025.

  • For Q4 2025, Interest Expenses fell 27.7% year-over-year to $5.0 million; the TTM value through Dec 2025 reached $19.7 million, down 17.18%, while the annual FY2025 figure was $19.7 million, 17.18% down from the prior year.
  • Interest Expenses for Q4 2025 was $5.0 million at Teladoc Health, up from $4.5 million in the prior quarter.
  • Across five years, Interest Expenses topped out at $6.8 million in Q4 2024 and bottomed at $4.5 million in Q2 2025.
  • The 4-year median for Interest Expenses is $5.6 million (2022), against an average of $5.4 million.
  • The largest annual shift saw Interest Expenses grew 23.62% in 2024 before it fell 27.7% in 2025.
  • A 4-year view of Interest Expenses shows it stood at $4.6 million in 2022, then rose by 20.68% to $5.5 million in 2023, then increased by 23.62% to $6.8 million in 2024, then dropped by 27.7% to $5.0 million in 2025.
  • Per Business Quant, the three most recent readings for TDOC's Interest Expenses are $5.0 million (Q4 2025), $4.5 million (Q3 2025), and $4.5 million (Q2 2025).